tiprankstipranks
RedHill Biopharma (RDHL)
NASDAQ:RDHL
US Market

RedHill Biopharma (RDHL) Income Statement

Compare
825 Followers

RedHill Biopharma Income Statement

Last quarter (Q2 2023), RedHill Biopharma's total revenue was $1.80M, a decrease of -90.21% from the same quarter last year. In Q2, RedHill Biopharma's net income was $761.00K. See RedHill Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 6.51M$ 61.80M$ 85.76M$ 64.36M$ 6.29M
Gross Profit
$ 3.05M$ 28.46M$ 36.35M$ 27.47M$ 4.03M
Operating Expenses
$ -9.56M$ 71.31M$ 117.49M$ 91.15M$ 47.23M
Depreciation and Amortization
$ 1.99M$ 8.12M$ 18.16M$ 8.81M$ 1.22M
EBITDA
$ 26.31M$ -42.84M$ -63.03M$ -54.94M$ -40.78M
Operating Income
$ 12.63M$ -42.84M$ -81.14M$ -63.68M$ -43.20M
Other Income/Expenses
$ 11.32M$ -28.82M$ -16.61M$ -12.49M$ 897.00K
Pretax Income
$ 23.95M$ -71.67M$ -97.74M$ -76.17M$ -42.30M
Net Income
$ 23.92M$ -59.24M$ -114.31M$ -89.02M$ -43.63M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 3.69$ -38.27$ -98.27$ -97.75$ -58.78
Diluted EPS
$ 3.69$ -38.27$ -98.27$ -97.75$ -58.78
Weighted Average Shares Outstanding
6.48M 1.55M 1.16M 910.69K 742.30K
Weighted Average Shares Outstanding (Diluted)
6.48M 1.55M 1.16M 910.69K 742.30K
Currency in USD

RedHill Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis